Marcus V. Agrela

1.4k total citations
4 papers, 104 citations indexed

About

Marcus V. Agrela is a scholar working on Infectious Diseases, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marcus V. Agrela has authored 4 papers receiving a total of 104 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 1 paper in Genetics and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Marcus V. Agrela's work include SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). Marcus V. Agrela is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). Marcus V. Agrela collaborates with scholars based in Brazil. Marcus V. Agrela's co-authors include Sérgio San Juan Dertkigil, Maria Luíza Moretti, Mílton A. Martins, Maria Isabel Cardoso Alonso‐Vale, Rafael Ludemann Camargo, Luciana C. Ribeiro, Eliana P. Araújo, Ana Flávia Bernardes, Iolanda de Fátima Lopes Calvo Tibério and Milena Monfort‐Pires and has published in prestigious journals such as Frontiers in Pharmacology, Viruses and Frontiers in Cardiovascular Medicine.

In The Last Decade

Marcus V. Agrela

3 papers receiving 103 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marcus V. Agrela Brazil	3	53	36	24	23	19	4	104
Maria Boylan Ireland	2	61 1.2×	20 0.6×	37 1.5×	21 0.9×	13 0.7×	2	104
André C. Palma Brazil	4	72 1.4×	25 0.7×	29 1.2×	12 0.5×	9 0.5×	7	95
Elena Vasilieva Russia	5	32 0.6×	11 0.3×	17 0.7×	22 1.0×	10 0.5×	20	121
Ana Flávia Bernardes Brazil	3	63 1.2×	24 0.7×	27 1.1×	10 0.4×	5 0.3×	4	84
N. V. Lomakin Russia	6	42 0.8×	33 0.9×	32 1.3×	19 0.8×	5 0.3×	29	126
Yujie Kong China	6	29 0.5×	27 0.8×	9 0.4×	21 0.9×	3 0.2×	21	121
Mariana Shumliakivska Germany	5	29 0.5×	17 0.5×	20 0.8×	33 1.4×	3 0.2×	7	97
Alfredo Iardino United States	5	17 0.3×	12 0.3×	7 0.3×	15 0.7×	25 1.3×	16	67
Mariella D’Angiò Italy	5	15 0.3×	16 0.4×	9 0.4×	12 0.5×	3 0.2×	8	57
Sabrina Herrera Colombia	4	29 0.5×	5 0.1×	16 0.7×	20 0.9×	8 0.4×	5	67

Countries citing papers authored by Marcus V. Agrela

Since Specialization

Citations

This map shows the geographic impact of Marcus V. Agrela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus V. Agrela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus V. Agrela more than expected).

Fields of papers citing papers by Marcus V. Agrela

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus V. Agrela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus V. Agrela. The network helps show where Marcus V. Agrela may publish in the future.

Co-authorship network of co-authors of Marcus V. Agrela

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus V. Agrela. A scholar is included among the top collaborators of Marcus V. Agrela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus V. Agrela. Marcus V. Agrela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Garcia, Márcia Teixeira, et al.. (2022). COINFECÇÃO TUBERCULOSE E COVID-19. The Brazilian Journal of Infectious Diseases. 26. 102455–102455.

2.

Camargo, Rafael Ludemann, Bruna Bombassaro, Milena Monfort‐Pires, et al.. (2022). Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019. Frontiers in Cardiovascular Medicine. 9. 847809–847809. 26 indexed citations

3.

Mansour, Eli, André C. Palma, Raisa G. Ulaf, et al.. (2021). Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin–Kallikrein System in Severe COVID-19. Viruses. 13(2). 309–309. 34 indexed citations

4.

Righetti, Renato Fraga, Fernanda Paula Roncon Santana, Marcus V. Agrela, et al.. (2018). Protective Effects of Anti-IL17 on Acute Lung Injury Induced by LPS in Mice. Frontiers in Pharmacology. 9. 1021–1021. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact